Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugh Ip

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
BMJ (Clinical Research Ed.)|August 20, 2008
Commentary: An "ethnic minority" medical studentHugh Ip
The International Journal of Biochemistry & Cell Biology|November 15, 2016
CD98 signals controlling tumorigenesisHugh Ip, Tariq Sethi
BMJ (Clinical Research Ed.)|May 17, 2008
Increasing diversity among cliniciansHugh Ip, I C McManus
Lancet (London, England)|August 13, 2013
Pleural effusions in a patient with tuberculosis on dialysisHugh Ip, Lucy Ellen Eyre Schomberg, Liju Ahmed
British Journal of Haematology|February 20, 2013
Low flow nocturnal oxygen therapy does not suppress haemoglobin levels or increase painful crises in sickle cell diseaseHugh Ip, Rachel Kesse-Adu, Jo Howard, et al.
Thorax|February 25, 2017
Let air out of the bowel to allow more air in the lungs: surgical treatment of weaning failureHugh Ip, Wen Ling Woo, Amir Darakhshan, et al.
Chest|December 3, 2014
Talc pleurodesis through indwelling pleural catheters for malignant pleural effusions: retrospective case series of a novel clinical pathwayLiju Ahmed, Hugh Ip, Deepak Rao, et al.
JRSM Short Reports|November 20, 2012
Managing patient pathways to achieve lung cancer waiting time targets: mixed methods studyHugh Ip, Tarik Amer, Michael Dangoor, et al.
BMC Pulmonary Medicine|August 29, 2019
Multidisciplinary approach to connective tissue disease (CTD) related pleural effusions: a four-year retrospective evaluationHugh Ip, Parthipan Sivakumar, Eugene Ace McDermott, et al.
Respirology (Carlton, Vic.)|April 20, 2022
Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study-2: Use of 2.5 mg alteplase as a starting intrapleural doseNatalia Popowicz, Hugh Ip, Estee P M Lau, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
BMJ (Clinical Research Ed.)|August 20, 2008
Commentary: An "ethnic minority" medical studentHugh Ip
The International Journal of Biochemistry & Cell Biology|November 15, 2016
CD98 signals controlling tumorigenesisHugh Ip, Tariq Sethi
BMJ (Clinical Research Ed.)|May 17, 2008
Increasing diversity among cliniciansHugh Ip, I C McManus
Lancet (London, England)|August 13, 2013
Pleural effusions in a patient with tuberculosis on dialysisHugh Ip, Lucy Ellen Eyre Schomberg, Liju Ahmed
British Journal of Haematology|February 20, 2013
Low flow nocturnal oxygen therapy does not suppress haemoglobin levels or increase painful crises in sickle cell diseaseHugh Ip, Rachel Kesse-Adu, Jo Howard, et al.
Thorax|February 25, 2017
Let air out of the bowel to allow more air in the lungs: surgical treatment of weaning failureHugh Ip, Wen Ling Woo, Amir Darakhshan, et al.
Chest|December 3, 2014
Talc pleurodesis through indwelling pleural catheters for malignant pleural effusions: retrospective case series of a novel clinical pathwayLiju Ahmed, Hugh Ip, Deepak Rao, et al.
JRSM Short Reports|November 20, 2012
Managing patient pathways to achieve lung cancer waiting time targets: mixed methods studyHugh Ip, Tarik Amer, Michael Dangoor, et al.
BMC Pulmonary Medicine|August 29, 2019
Multidisciplinary approach to connective tissue disease (CTD) related pleural effusions: a four-year retrospective evaluationHugh Ip, Parthipan Sivakumar, Eugene Ace McDermott, et al.
Respirology (Carlton, Vic.)|April 20, 2022
Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study-2: Use of 2.5 mg alteplase as a starting intrapleural doseNatalia Popowicz, Hugh Ip, Estee P M Lau, et al.
Pageof 2